Human APP/Protease Nexin II (Research Grade Solanezumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB9919-SP	R&D Systems MAB9919SP	25 μg
MAB9919-100	R&D Systems MAB9919100	100 μg

Description

APP Monoclonal specifically detects APP in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: APP
• Dilution: Flow Cytometry 0.25μg/10⁶ cells, CyTOF-ready
• Classification: Monoclonal
• Form: Supernatant
• Target Species: Human
• Gene Alias: Amyloid beta, amyloid beta (A4) precursor protein-binding, family B, member 2, amyloid beta A4 precursor protein-binding family B member 2, Amyloid beta precursor protein, APP, beta Amyloid, Protease Nexin II
• Immunogen: Human APP/Protease Nexin II
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5mg/mL in sterile PBS.
• Test Specificity: Detects Human APP/Protease Nexin II based on Solanezumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Solanezumab. This product is for research use only.

• Clone: Hu13
• Applications: CyTOF, Flow Cytometry
• Conjugate: Unconjugated
• Host Species: Human
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 351
• Isotype: IgG1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.